| __timestamp | Agios Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 79838000 |
| Thursday, January 1, 2015 | 141827000 | 121816000 |
| Friday, January 1, 2016 | 220163000 | 117633000 |
| Sunday, January 1, 2017 | 292681000 | 117456000 |
| Monday, January 1, 2018 | 341324000 | 171984000 |
| Tuesday, January 1, 2019 | 410894000 | 257452000 |
| Wednesday, January 1, 2020 | 367470000 | 477643000 |
| Friday, January 1, 2021 | 256973000 | 540684000 |
| Saturday, January 1, 2022 | 279910000 | 651496000 |
| Sunday, January 1, 2023 | 288903000 | 666563000 |
| Monday, January 1, 2024 | 301286000 |
Unleashing the power of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. From 2014 to 2023, PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc. have demonstrated distinct strategies in their R&D investments.
PTC Therapeutics has shown a remarkable increase in R&D spending, with a growth of over 730% from 2014 to 2023. This surge underscores their aggressive pursuit of new therapies and treatments. In contrast, Agios Pharmaceuticals, while also increasing their R&D budget, has maintained a more steady growth, with a 188% increase over the same period.
The year 2020 marked a pivotal point for PTC, as their R&D expenses surpassed Agios for the first time, highlighting a strategic shift. This trend continued, with PTC's spending reaching its peak in 2023, indicating a robust pipeline and a strong focus on future innovations.
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Ascendis Pharma A/S and Agios Pharmaceuticals, Inc.
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
R&D Insights: How Apellis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.